Vol. 29 (4) 2022
sVCAM-1, and TGFβ1 in chronic phase, chronic myeloid leukemia patients treated with tyrosine kinase inhibitors The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 163–173. www.Ejimmunology.org https://doi.org/10.55133/eji.290416 Muhamad R. Abdel...
Vol. 29 (4) 2022
Serum IgG4 level for malignancy prediction in indeterminate thyroid nodules among patients with or without autoimmune thyroid disease The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 156–162. www.Ejimmunology.org...
Vol. 29 (4) 2022
Serum interleukin-33 (IL-33) in children with active systemic lupus erythematosus: A cross-sectional study The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 148–155. www.Ejimmunology.org https://doi.org/10.55133/eji.290414 Rana I. Abd-Elazeem1,...
Vol. 29 (4) 2022
Detection of ERG11 gene in fluconazole resistant urinary candida isolates The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 134–147. www.Ejimmunology.org https://doi.org/10.55133/eji.290413 Manal El Said1,2, Hala Badawi1, Doaa Gamal3, Dalia...
Vol. 29 (4) 2022
Gli-similar 3 (GLIS3) rs7020763 (C>G) polymorphism in patients with type 2 diabetes mellitus The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 125–133. www.Ejimmunology.org https://doi.org/10.55133/eji.290412 Lubna E. Mohamed1, Eman S....
Vol. 29 (4) 2022
Frequency of ragweed sensitization and allergy among patients with respiratory allergy The Egyptian Journal of Immunology Volume 29 (4), October, 2022 Pages: 115–124. www.Ejimmunology.org https://doi.org/10.55133/eji.290411 Dina H. Esmail1, Zeinab A. Ashour1, Dina S....
